215 related articles for article (PubMed ID: 11832771)
21. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y
Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite allelotyping of chinese nasopharyngeal carcinomas.
Lung ML; Choi CV; Kong H; Yuen PW; Kwong D; Sham J; Wei WI
Anticancer Res; 2001; 21(4B):3081-4. PubMed ID: 11712814
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.
Shridhar V; Sun QC; Miller OJ; Kalemkerian GP; Petros J; Smith DI
Oncogene; 1997 Nov; 15(22):2727-33. PubMed ID: 9400999
[TBL] [Abstract][Full Text] [Related]
24. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
[TBL] [Abstract][Full Text] [Related]
25. Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
El-Mokadem I; Kidd T; Pratt N; Fleming S; Nabi G
Oncotarget; 2016 Nov; 7(45):73045-73054. PubMed ID: 27682877
[TBL] [Abstract][Full Text] [Related]
26. [Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene].
Maestro de las Casas ML; Sanz-Casla MT; del Barco V; Moreno J; Zanna I; Redondo E; Fernández C; Izquierdo L; Resel Estévez L
Arch Esp Urol; 2000 Sep; 53(7):603-9. PubMed ID: 11037653
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity in laryngeal cancer.
Rogowski M; Walenczak I; Pepiński W; Skawrońska M; Sieśkiewicz A; Klatka J
Rocz Akad Med Bialymst; 2004; 49():262-4. PubMed ID: 15631354
[TBL] [Abstract][Full Text] [Related]
29. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.
Chan KL; Lee JM; Guan XY; Fan ST; Ng IO
Cancer; 2002 Jun; 94(12):3179-85. PubMed ID: 12115350
[TBL] [Abstract][Full Text] [Related]
30. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
Jones TD; Eble JN; Wang M; Maclennan GT; Jain S; Cheng L
Cancer; 2005 Sep; 104(6):1195-203. PubMed ID: 16047350
[TBL] [Abstract][Full Text] [Related]
31. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.
Harima Y; Harima K; Sawada S; Tanaka Y; Arita S; Ohnishi T
Clin Cancer Res; 2000 Mar; 6(3):1079-85. PubMed ID: 10741737
[TBL] [Abstract][Full Text] [Related]
33. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
Herbers J; Schullerus D; Chudek J; Bugert P; Kanamaru H; Zeisler J; Ljungberg B; Akhtar M; Kovacs G
J Pathol; 1998 Jan; 184(1):58-62. PubMed ID: 9582528
[TBL] [Abstract][Full Text] [Related]
34. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas.
Wright K; Wilson PJ; Kerr J; Do K; Hurst T; Khoo SK; Ward B; Chenevix-Trench G
Oncogene; 1998 Sep; 17(9):1185-8. PubMed ID: 9764830
[TBL] [Abstract][Full Text] [Related]
35. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
36. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M
J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565
[TBL] [Abstract][Full Text] [Related]
37. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
38. Allelotype of endometrial carcinoma.
Fujino T; Risinger JI; Collins NK; Liu FS; Nishii H; Takahashi H; Westphal EM; Barrett JC; Sasaki H; Kohler MF
Cancer Res; 1994 Aug; 54(16):4294-8. PubMed ID: 8044774
[TBL] [Abstract][Full Text] [Related]
39. Allelotype of human bladder cancer.
Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
[TBL] [Abstract][Full Text] [Related]
40. Distal nephron renal tumors: microsatellite allelotype.
Polascik TJ; Cairns P; Epstein JI; Fuzesi L; Ro JY; Marshall FF; Sidransky D; Schoenberg M
Cancer Res; 1996 Apr; 56(8):1892-5. PubMed ID: 8620510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
